Mylan and Biocon Neulasta biosimilar knocked back by FDA
October 11, 2017Research and Development, Sales and Marketing Amgen, Biocon, Mylan, Neulasta, biotech, drugs, pharma, pharmaceutical
Mylan and Biocon’s biosimilar version of Amgen’s blockbuster, Neulasta (pegfilgrastim), will have to wait a bit longer before getting the …
Allergan settles gender discrimination case for $4m
October 11, 2017Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical
It could have been much worse for Allergan, after it agreed to pay $4 million to resolve a lawsuit alleging …
NHS Scotland appoints new Chief Scientist
October 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Scotland, biotech, drugs, pharma, pharmaceutical
NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill …
Use of antacids found to promote liver disease
October 10, 2017Manufacturing and Production, Research and Development biotech, drugs, liver disease, pharma, pharmaceutical
A study emerging from the University of California, San Diego, has revealed a correlation between the use of common acid …
Scottish government reveals extra funding for mental health
October 10, 2017Manufacturing and Production, Medical Communications Scotland, biotech, drugs, mental health, pharma, pharmaceutical
The Scottish government, on Mental Health Day, has revealed that it will boost spending on mental health services by £500,000. …
California signs into law transparency over drug pricing
October 10, 2017Manufacturing and Production, Sales and Marketing Drug pricing, biotech, california, drugs, pharma, pharmaceutical
In a move that is guaranteed to result in further lawsuits and acrimony, California has signed into law a requirement …
GSK ranked at bottom of ‘good governance’ report
October 10, 2017Manufacturing and Production, Medical Communications Diageo, GSK, biotech, drugs, pharma, pharmaceutical
A new report emerging from the Institute of Directors placed UK pharma giant, GSK, in last place out of 103 …
J&J exits insulin pump business, rival looks to scoop patients
October 10, 2017Manufacturing and Production Johnson & Johnson, biotech, diabetes, drugs, pharma, pharmaceutical
Johnson & Johnson’s Animas Corporation will cease business and close operations after the pharma giant could not find a buyer …
Harnessing the power of the immune system
October 9, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Cancer Research UK, immunotherapy, pharma, pharmaceuticals
Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies …
Roche’s 99% accurate Zika test receives FDA approval
October 9, 2017Sales and Marketing Roche, Zika, biotech, drugs, pharma, pharmaceutical
Roche has revealed that the FDA has given approval to its cobas Zika test to determine whether a blood sample …
AstraZeneca’s Tagrisso secures Breakthrough Therapy Designation in first-line NSCLC
October 9, 2017Sales and Marketing AstraZeneca, Cancer, NSCLC, immunotherapy, lung cancer
AstraZeneca has announced that its targeted therapy, Tagrisso (osimertinib), has been awarded Breakthrough Therapy Designation by the FDA for the …
Trump sweeps away birth control coverage
October 9, 2017Medical Communications, Sales and Marketing President trump, Trump, biotech, birth control, drugs, pharma, pharmaceutical
Part of Obama’s Affordable Care Act included the provision that employer-provided health insurance must cover birth control, President Trump has …
China to accelerate drug approvals with overseas trial data
October 9, 2017Research and Development, Sales and Marketing China, drug approvals, pharma, pharmaceuticals
In a bid to speed up access to medicines for patients, China has revealed it intends to incorporate data from …
Battery implant approved to treat sleep apnea
October 9, 2017Sales and Marketing FDA, biotech, drugs, pharma, pharmaceutical
The FDA has announced the approval of a new form of treatment for central sleep apnea, in the form of …
Sanofi promotes global head of diabetes to expand role
October 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, biotech, diabetes, drugs, pharma, pharmaceutical
Sanofi has promoted Stefan Oelrich to the position of Executive Vice President of Diabetes and Cardiovascular (DCV), giving him a …
Top Ten most popular articles on Pharmafile.com this week
October 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
The week has flown by and was packed with a number of shocking stories. With the ongoing uncertainty regarding Brexit, …
AbbVie hit with $140m fine over fraudulent marketing of Androgel
October 6, 2017Medical Communications, Sales and Marketing AbbVie, androgel, biotech, drugs, pharma, pharmaceutical
AbbVie has been stung with a $140 million damages award to a man that suffered a heart attack after using …
At least 40% of Afghanistan’s medicine imported illegally, union claims
October 6, 2017Manufacturing and Production, Medical Communications, Sales and Marketing afghanistan, pharma, pharmaceuticals
New damning allegations have arisen concerning Afghanistan’s pharmaceutical industry, as the Medicine Importers Union claims that at least 40% of …
Bayer forced to halt huge study into key drug
October 6, 2017Medical Communications, Research and Development Bayer, Janssen, Xarelto, biotech, drugs, pharma, pharmaceutical
Bayer, and development partner Janssen, have been forced to stop a Phase 3 trial looking at expanding the indication of …
South Africa’s over-charging case against Aspen dissolves, remains against big names
October 6, 2017Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical
South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
